Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Lipocalin 2 is present in the EAE brain and is modulated by natalizumab.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
Stress and the risk of multiple sclerosis.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Stress signaling etches heritable marks on chromatin.
Pages
« first
‹ previous
…
92
93
94
95
96
97
98
99
100
…
next ›
last »